Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPAR alpha agonists by in silico studies and biochemical evaluation
文献类型:期刊论文
作者 | Li, Yue1,2; Lv, Mengjia3,4; Shen, Meiling1; Gu, Xi1; Zhang, Li2; Liu, Xingyong2; Chen, Jing4; Gong, Likun3,4; Zuo, Zhili1 |
刊名 | JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS |
出版日期 | 2023-09-06 |
页码 | 16 |
ISSN号 | 0739-1102 |
关键词 | NAFLD PPAR alpha agonist virtual screening biochemical evaluation |
DOI | 10.1080/07391102.2023.2256867 |
通讯作者 | Chen, Jing(jingchen@simm.ac.cn) ; Gong, Likun(lkgong@simm.ac.cn) ; Zuo, Zhili(zuozhili@mail.kib.ac.cn) |
英文摘要 | Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, whose pathologic features include dysregulated glucose homeostasis and lipid accumulation. Peroxisome proliferators-activated receptor a (PPAR alpha) is a key regulator of fatty acid metabolism and ketogenesis due to its regulatory pathways involve activating fatty acid uptake, accelerating fatty acid oxidation, inhibiting gluconeogenesis, and suppressing inflammation and fibrosis. Therefore, PPAR alpha is considered as a potential target for the treatment of NAFLD and some agonists have entered clinical trials, which drove us to discover more novel PPAR alpha agonists. In current work, new 3H-benzo[b] [1,4] diazepine PPAR alpha agonists were identified from the ChemDiv database by pharmacophore modeling, molecular docking, derivative structure search, and bioassays, where compound LY-2 and its derivatives (LY-10 similar to LY-19) were discovered to promote the expression of PPAR alpha downstream gene, carnitine palmitoyl transterase-1 alpha (cpt1 alpha). Among these active compounds, the EC50 value of LY-2 against increasing cpt1 alpha was 2.169 mu M. Furthermore, the effect of LY-2 on cpt1a was weakened when PPAR alpha knock down, which confirmed that it is a PPAR alpha agonist again. Finally, the results from molecular dynamics simulations and binding free energy calculations showed that pi-pi stacking and hydrogen bonding interactions played key roles in the binding of LY-2 and PPAR alpha protein and their complex maintained a stable structure to facilitate LY-2 to have a better binding affinity with PPAR alpha protein. Taken together, compound LY-2 might be a novel lead compound for the development of potent PPAR alpha agonists. [GRAPHICS] . |
WOS关键词 | FATTY-ACID OXIDATION ; GROMACS |
资助项目 | General Program of Applied Basic Research of Yunnan Province[2020FB28] ; Yunnan Science and Technology Major Project[202202AA100012] |
WOS研究方向 | Biochemistry & Molecular Biology ; Biophysics |
语种 | 英语 |
出版者 | TAYLOR & FRANCIS INC |
WOS记录号 | WOS:001065166300001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/306155] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Chen, Jing; Gong, Likun; Zuo, Zhili |
作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Chi, Kunming, Yunnan, Peoples R China 2.Sichuan Univ Sci & Engn, Sch Chem Engn, Zigong, Sichuan, Peoples R China 3.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Yue,Lv, Mengjia,Shen, Meiling,et al. Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPAR alpha agonists by in silico studies and biochemical evaluation[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS,2023:16. |
APA | Li, Yue.,Lv, Mengjia.,Shen, Meiling.,Gu, Xi.,Zhang, Li.,...&Zuo, Zhili.(2023).Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPAR alpha agonists by in silico studies and biochemical evaluation.JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS,16. |
MLA | Li, Yue,et al."Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPAR alpha agonists by in silico studies and biochemical evaluation".JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023):16. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。